Table 2.
Medication and physical examination findings of the study population
| All patients (n = 286) | PCR positive (n = 157) | PCR negative (n = 129) | p | |
|---|---|---|---|---|
| Medications | ||||
| Hydroxychloroquine | 257 (89.9) | 155 (98.7) | 128 (99.2) | 0.991 |
| Azithromycin | 183 (64) | 99 (64.7) | 84 (65.6) | 0.872 |
| Oseltamivir | 181 (63.3) | 102 (65) | 79 (61.2) | 0.539 |
| Moxifloxacin | 92 (32.2) | 60 (38.2) | 32 (24.8) | 0.016 |
| Favipiravir | 53 (18.5) | 33 (21.4) | 20 (15.6) | 0.225 |
| Lopinavir/ritonavir | 22 (7.7) | 21 (13.7) | 1 (0.8) | <0.001 |
| Tocilizumab | 15 (5.2) | 14 (9.1) | 1 (0.8) | 0.002 |
| Other antibiotics | 27 (9.4) | 20 (12.9) | 7 (5.5) | 0.042 |
| Physical examination findings | ||||
| Systolic blood pressure (mmHg) | 119.2 ± 20.1 | 117.1 ± 18.6 | 121.9 ± 21.6 | 0.094 |
| Diastolic blood pressure (mmHg) | 71.3 ± 9.4 | 70.9 ± 9 | 71.8 ± 9.9 | 0.508 |
| Heart rate (/min.) | 86.1 ± 12.5 | 87.3 ± 13.2 | 85.1 ± 11.2 | 0.232 |
| Oxygen saturation (%) | 94.1 ± 4.7 | 93.9 ± 4.8 | 94.1 ± 4.6 | 0.769 |
| Respiratory rate (/min.) | 18.4 ± 3.9 | 18.4 ± 3.7 | 18.3 ± 4.1 | 0.957 |
| Computed tomography findings | ||||
| Total score of computed tomography Initial | ||||
| 0 | 91 (31.8) | 39 (24.8) | 52 (40.3) | 0.084 |
| 1 | 131 (45.8) | 81 (51.6) | 50 (38.8) | |
| 2 | 46 (16.1) | 26 (16.6) | 20 (15.5) | |
| 3 | 8 (2.8) | 5 (3.2) | 3 (2.3) | |
| 4 | 10 (3.5) | 6 (3.8) | 4 (3.1) | |
| Follow-up | ||||
| 1 | 180 (62.9) | 102 (64.9) | 78 (60.5) | |
| 2 | 69 (24.1) | 38 (24.2) | 31 (24.1) | 0.185 |
| 3 | 18 (6.4) | 9 (5.7) | 9 (6.9) | |
| 4 | 19 (6.6) | 8 (5.2) | 11 (8.5) | |